spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

4th Annual Genome Editing Congress

Oxford Global Events - Gene Editing

8-9 November 2018
London, UK

Oxford Global is proud to present its 4thAnnual Genome Editing Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.

Our Genome Editing Congress will feature over 20 presentations and case studies focused on the latest developments in gene editing techniques and case studies on the therapeutic applications of genome editing technologies. 

World renowned experts will give over 20 presentations across 2 interactive streams, including;

·         Genome Editing Techniques and Technologies

·         Therapeutic Applications of Genome Editing

View the Agenda here>> https://bit.ly/2s1kWe7

This event will be co-located with the highly established 10th Annual Next Generation Sequencing and Clinical Diagnostics Congress, 6th Annual Single Cell Analysis Congress and the Synthetic Biology Congress.

Free Pre-Congress Live Webinars

Approaching CRISPR Intellectual Property Issues
Hosted by Catherine Coombes, Patent Director, HGF Limited

Register for free today: https://bit.ly/2J2gR0s

Design, Deliver & Detect: Considerations For Optimized In Vitro And Ex Vivo CRISPR Applications.
Hosted by Eric Paul Bennett, Associate Professor, University of Copenhagen

Register for free today: https://bit.ly/2IUsHxL

Can’t make the date? Register today and the recording of the webinar will be sent to you afterwards.

For further information, prices & group discounts please contact d.dalby@oxfordglobal.co.uk

 

phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2tHrM9q
email London
 
Print this page
Send to a friend
   
spacer
Industry Events

Synthetic Biology Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its Synthetic Biology Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.
More info >>

White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>


News and Press Releases

BioIVT Webinar Will Discuss How to Optimize Microbiome Research

BioIVT, a leading provider of research models and services for drug development, today announced that it is hosting a webinar entitled “The Microbiome: Understanding Why Collection and Processing Matters” at 11 a.m. ET on July 25.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement